10X Genomics (TXG) PT Raised to $47 at Piper Sandler
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $88.50 +3.26%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Join SI Premium – FREE
Piper Sandler analyst David Westenberg raised the price target on 10X Genomics (NASDAQ: TXG) to $47.00 (from $42.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Argus Starts 10X Genomics (TXG) at Buy
- Envista Holdings Corp. (NVST) PT Lowered to $26 at BMO Capital Following China VBP Commentary
- PB Fintech Limited (POLICYBZ:IN) PT Lowered to INR1,425 at Investec
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
